E-GEOD-51371 - Sensitivity to proteasome inhibition and in vivo growth properties of MCL cells

Status
Released on 18 October 2013, last updated on 3 June 2014
Organism
Homo sapiens
Samples (7)
Array (1)
Protocols (7)
Description
MCL cells resistant to bortezomib show distinct tumor growth in vivo when compared to their bortezomib-sensitive counterpart We used microarrays to detail the factors underlying the increased tumorigenicity of bortezomib-resistant cells in vivo Global RNA expression in tumors harvested from SCID mice and derived from either bortezomib-sensitive or bortezomib-resistant MCL cell lines
Experiment type
transcription profiling by array 
Contacts
MIAME
PlatformsProtocolsVariablesProcessedRaw
Files
Investigation descriptionE-GEOD-51371.idf.txt
Sample and data relationshipE-GEOD-51371.sdrf.txt
Raw data (1)E-GEOD-51371.raw.1.zip
Processed data (1)E-GEOD-51371.processed.1.zip
Array designA-GEOD-13667.adf.txt
Links